Stay updated on ZUMA-5 Indolent NHL Clinical Trial
Sign up to get notified when there's something new on the ZUMA-5 Indolent NHL Clinical Trial page.

Latest updates to the ZUMA-5 Indolent NHL Clinical Trial page
- Check6 days agoChange DetectedA site-wide NIH announcement about a terminology transition appears above the 403 error page. The site revision identifier also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check34 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, replacing the expected content and navigation with an access-denied message. This indicates the page is currently inaccessible due to permission restrictions.SummaryDifference20%

- Check41 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the page.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page's revision stamp has been updated to Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor metadata update to the page.SummaryDifference0.0%

- Check62 days agoChange DetectedTwo NIH grant/contract entries were added to the study's external identifiers for 2017 and 2023, indicating funding acknowledgments associated with those years.SummaryDifference0.1%

Stay in the know with updates to ZUMA-5 Indolent NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZUMA-5 Indolent NHL Clinical Trial page.